CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	6 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net loss	$ (9,042,086)	$ (11,832,388)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	212,025	42,825
Fair value of vested options issued to officers, directors and employees	1,313,331	873,023
Change in fair value of warrant liability	2,178,859	6,852,518
Equity based compensation		13,238
Common stock issued for consulting services	337,500
Bad debt expense	16,144
Change in operating assets and liabilities:
Accounts receivable	50,499	(110,803)
Prepaid expenses and deposits	59,134	54,762
Accounts payable and accrued liabilities	344,572	217,714
Deferred revenue	267,486
Net cash used in operating activities	(4,262,536)	(3,889,111)
Cash flows from investing activities:
Purchase of property and equipment	(109,581)	(30,061)
Net cash used in investing activities	(109,581)	(30,061)
Cash flows from financing activities:
Net proceeds from sale of common stock		2,000,000
Proceeds from sale of Series A preferred stock		5,500,000
Proceeds from exercise of warrants		150,000
Purchase and cancellation of previously issued warrants		(50,000)
Net cash provided by financing activities		7,600,000
Net (decrease) increase in cash and cash equivalents	(4,372,117)	3,680,828
Cash and cash equivalents at beginning of period	6,360,301	724,782
Cash and cash equivalents at end of period	1,988,184	4,405,610
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest
Cash paid during period for taxes
Non-cash investing and financing activities:
Common stock issued in exchange for previously incurred debt
Common stock issued for cashless exercise of options and warrants	19,570
Property, plant and equipment acquired, and included in accounts payable	$ 7,794